Reuven Sandyk
#103,797
Most Influential Person Now
Reuven Sandyk's AcademicInfluence.com Rankings
Reuven Sandykmedical Degrees
Medical
#1255
World Rank
#1575
Historical Rank
Neurology
#114
World Rank
#173
Historical Rank
Reuven Sandykphilosophy Degrees
Philosophy
#4151
World Rank
#6557
Historical Rank
Logic
#1675
World Rank
#2488
Historical Rank
Download Badge
Medical Philosophy
Why Is Reuven Sandyk Influential?
(Suggest an Edit or Addition)Reuven Sandyk's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Controlled clinical trial of cannabidiol in Huntington's disease (1991) (280)
- The relationship between diabetes mellitus and Parkinson's disease. (1993) (205)
- Open label evaluation of cannabidiol in dystonic movement disorders. (1986) (140)
- Magnetic stimulation in the treatment of partial seizures. (1991) (126)
- L-tryptophan in neuropsychiatric disorders: a review. (1992) (111)
- Successful treatment of multiple sclerosis with magnetic fields. (1992) (96)
- The hypothalamus in Parkinson Disease (1987) (91)
- Naloxone abolishes self‐injuring in a mentally retarded child (1985) (89)
- Marijuana and Tourette's syndrome. (1988) (86)
- The hypothalamus in Parkinson's disease. (1987) (85)
- Zinc deficiency in attention-deficit hyperactivity disorder. (1990) (78)
- Pineal and habenula calcification in schizophrenia. (1992) (77)
- The endogenous opioid system in neurological disorders of the basal ganglia. (1985) (75)
- Mexiletine for thalamic pain syndrome. (1990) (71)
- Serotonin in involuntary movement disorders. (1988) (70)
- Relevance of the habenular complex to neuropsychiatry: a review and hypothesis. (1991) (68)
- Nocturnal plasma melatonin and alpha-melanocyte stimulating hormone levels during exacerbation of multiple sclerosis. (1992) (68)
- Estrogens and the pathophysiology of Parkinson's disease. (1989) (68)
- Cigarette smoking: effects on cognitive functions and drug-induced parkinsonism in chronic schizophrenia. (1993) (66)
- L-dopa induced "serotonin syndrome" in a parkinsonian patient on bromocriptine. (1986) (64)
- SEROTONERGIC MECHANISMS IN AMYOTROPHIC LATERAL SCLEROSIS (2006) (62)
- Melatonin as a proconvulsive hormone in humans. (1992) (61)
- Magnetic fields in the therapy of parkinsonism. (1992) (60)
- Autonomic functions in the early stages of Parkinson's disease. (1992) (60)
- L-dopa in uremic patients with the restless legs syndrome. (1987) (57)
- The association of diabetes mellitus with dementia in Parkinson's disease. (1992) (56)
- Naloxone treatment of L-dopa-induced dyskinesias in Parkinson's disease. (1986) (55)
- Baclofen-induced memory impairment. (1985) (54)
- Sensory symptoms (1985) (52)
- Magnetic fields in the treatment of Parkinson's disease. (1992) (52)
- Increased incidence and severity of neuroleptic-induced movement disorder in pinealectomized rats. (1989) (52)
- Is postmenopausal osteoporosis related to pineal gland functions? (1992) (51)
- The operculum syndrome. (1983) (48)
- Tobacco addiction as a marker of age at onset of schizophrenia. (1991) (47)
- The effects of naloxone in tourette's syndrome (1985) (45)
- Is negative schizophrenia a variant of parkinsonism (1990) (44)
- The co-occurrence of multiple sclerosis and migraine headache: the serotoninergic link. (1994) (44)
- Persistent tardive dyskinesia and neuroleptic effects on glucose tolerance (1989) (43)
- Naloxone abolishes obsessive-compulsive behavior in Tourette's syndrome. (1987) (43)
- Pineal melatonin in schizophrenia: a review and hypothesis. (1990) (43)
- Parkinsonism due to subdural hematoma. Case report. (1983) (42)
- Possible role of pineal melatonin in the mechanisms of aging. (1990) (40)
- Nocturnal melatonin secretion in multiple sclerosis patients with affective disorders. (1993) (39)
- Rapid normalization of visual evoked potentials by picoTesla range magnetic fields in chronic progressive multiple sclerosis. (1994) (39)
- Further observations on the unique efficacy of picoTesla range magnetic fields in Parkinson's disease. (1993) (38)
- Weak electromagnetic fields attenuate tremor in multiple sclerosis. (1994) (38)
- Pain and sensory symptoms in Parkinson's disease. (1988) (37)
- L-Tryptophan in the treatment of restless legs syndrome. (1986) (35)
- Pyridoxine improves drug-induced parkinsonism and psychosis in a schizophrenic patient. (1990) (35)
- Reversal of captopril-induced psychosis with naloxone. (1985) (35)
- Alzheimer's disease: improvement of visual memory and visuoconstructive performance by treatment with picotesla range magnetic fields. (1994) (34)
- Reversal of visual neglect in Parkinson's disease by treatment with picoTesla range magnetic fields. (1993) (33)
- Resolution of longstanding symptoms of multiple sclerosis by application of picoTesla range magnetic fields. (1993) (33)
- Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. (1993) (32)
- The effects of L-tryptophan on haloperidol-induced movement disorder in the rat. (1987) (31)
- Vitamin B12 and its relationship to age of onset of multiple sclerosis. (1993) (31)
- Weak magnetic fields as a novel therapeutic modality in Parkinson's disease. (1992) (30)
- The pineal gland and spontaneous abortions: implications for therapy with melatonin and magnetic field. (1992) (30)
- Tourette syndrome and the opioid system (1985) (30)
- Improvement of right hemispheric functions in a child with Gilles de la Tourette's syndrome by weak electromagnetic fields. (1995) (30)
- Pineal melatonin functions: possible relevance to Parkinson's disease. (1990) (30)
- The pineal gland in multiple sclerosis. (1991) (30)
- Magnetic fields normalize visual evoked potentials and brainstem auditory evoked potentials in multiple sclerosis. (1993) (30)
- Improvement by picoTesla range magnetic fields of perceptual-motor performance and visual memory in a patient with chronic progressive multiple sclerosis. (1994) (29)
- The relationship of pineal calcification to cortical atrophy in schizophrenia. (1991) (29)
- Is the pineal gland involved in the pathogenesis of endometrial carcinoma. (1992) (29)
- Multiple sclerosis: the role of the pineal gland in its timing of onset and risk of psychiatric illness. (1993) (29)
- Multiple sclerosis: the role of puberty and the pineal gland in its pathogenesis. (1993) (29)
- Demyelination as an epiphenomenon in multiple sclerosis. (1993) (28)
- Weak magnetic fields in the treatment of Parkinson's disease with the "on-off" phenomenon. (1992) (28)
- Cannabidiol in dystonic movement disorders (1986) (28)
- Estrogen's impact on cognitive functions in multiple sclerosis. (1996) (28)
- Fulminating encephalopathy associated with Shigella flexneri infection. (1983) (28)
- Attenuation of reserpine-induced catalepsy by melatonin and the role of the opioid system. (1989) (27)
- Atrophy of the cerebellar vermis: relevance to the symptoms of schizophrenia. (1991) (27)
- Magnetic fields and seasonality of affective illness: implications for therapy. (1991) (26)
- The influence of the pineal gland on migraine and cluster headaches and effects of treatment with picoTesla magnetic fields. (1992) (26)
- Neuroleptic-induced “painful legs and moving toes” syndrome: successful treatment with clonazepam and baclofen (1990) (26)
- Opiates in the restless legs syndrome. (1987) (25)
- The relationship of the reticular system to the primary pathoetiology of Parkinson's disease. (1988) (25)
- The pineal gland and the mode of onset of schizophrenia. (1992) (25)
- The significance of eye blink rate in parkinsonism: a hypothesis. (1990) (25)
- The protective function of the pineal gland in tardive dyskinesia. (1988) (25)
- Reversal of a visuoconstructional deficit in Parkinson's disease by application of external magnetic fields: a report of five cases. (1994) (25)
- The relationship of negative schizophrenia to parkinsonism. (1990) (24)
- Freezing of gait in Parkinson's disease is improved by treatment with weak electromagnetic fields. (1996) (24)
- Resolution of Lhermitte's sign in multiple sclerosis by treatment with weak electromagnetic fields. (1995) (24)
- Spinal cord mechanisms in amitriptyline responsive restless legs syndrome in Parkinson's disease. (1988) (24)
- The restless legs syndrome (Ekbom's syndrome). (1983) (24)
- Multiple sclerosis: improvement of visuoperceptive functions by picoTesla range magnetic fields. (1994) (24)
- Efficacy of a combination of sodium valproate and baclofen in Meige's disease (idiopathic orofacial dystonia). (1982) (24)
- Treatment with weak electromagnetic fields improves fatigue associated with multiple sclerosis. (1996) (24)
- Therapeutic effects of alternating current pulsed electromagnetic fields in multiple sclerosis. (1997) (23)
- Immediate recovery of cognitive functions and resolution of fatigue by treatment with weak electromagnetic fields in a patient with multiple sclerosis. (1997) (23)
- Reversal of micrographia in Parkinson's disease by application of picoTesla range magnetic fields. (1994) (23)
- Choroid plexus calcification as a possible marker of hallucinations in schizophrenia. (1993) (23)
- Accelerated growth of malignant melanoma by levodopa in Parkinson's disease and role of the pineal gland. (1992) (23)
- A drug naive parkinsonian patient successfully treated with weak electromagnetic fields. (1994) (23)
- Relapsing lumbosacral plexus neuropathy. Report of two cases. (1991) (23)
- Tardive dyskinesia and glucose metabolism. (1986) (23)
- Oculogyric crisis induced by lithium carbonate. (1984) (23)
- The relationship of pineal calcification and melatonin secretion to the pathophysiology of tardive dyskinesia and Tourette's syndrome. (1991) (23)
- Nocturnal melatonin secretion in suicidal patients with multiple sclerosis. (1993) (23)
- Excessive yawning and progressive supranuclear palsy. (1987) (22)
- Pineal gland calcification and tardive dyskinesia (1990) (22)
- Baclofen in hemifacial spasm. (1987) (22)
- Opiatergic and dopaminergic function and Lesch-Nyhan syndrome. (1985) (22)
- Resolution of sleep paralysis by weak electromagnetic fields in a patient with multiple sclerosis. (1997) (22)
- The pineal gland and multiple sclerosis. (1992) (22)
- Determination of pulmonary artery occlusion of wedge pressure with the Swan-Ganz floating catheter. (1982) (22)
- Diurnal variations in vision and relations to circadian melatonin secretion in multiple sclerosis. (1995) (22)
- Reversal of a body image disorder (macrosomatognosia) in Parkinson's disease by treatment with AC pulsed electromagnetic fields. (1998) (22)
- Treatment with electromagnetic fields reverses the long-term clinical course of a patient with chronic progressive multiple sclerosis. (1997) (22)
- Long term beneficial effects of weak electromagnetic fields in multiple sclerosis. (1995) (22)
- Treatment with AC pulsed electromagnetic fields improves olfactory function in Parkinson's disease. (1999) (21)
- Post-amputation phantom pain and autonomous stump movements responsive to doxepin. (1987) (21)
- The effects of external picoTesla range magnetic fields on the EEG in Parkinson's disease. (1993) (21)
- Antioxidants in the treatment of schizophrenia. (1992) (20)
- Further observations on the effects of external picoTesla range magnetic fields on visual memory and visuospatial functions in multiple sclerosis. (1994) (20)
- Rapid improvement of visuoperceptive functions by picoTesla range magnetic fields in patients with Parkinson's disease. (1993) (20)
- Experimental models of schizophrenia. (1991) (20)
- The operculum syndrome. A case report. (1983) (20)
- Influence of the pineal gland on the expression of experimental allergic encephalomyelitis: possible relationship to the aquisition of multiple sclerosis. (1997) (19)
- Age-related disruption of circadian rhythms: possible relationship to memory impairment and implications for therapy with magnetic fields. (1991) (19)
- Serotonergic neuronal atrophy with synaptic inactivation, not axonal degeneration, are the main hallmarks of multiple sclerosis. (1998) (19)
- Melatonin and maturation of REM sleep. (1992) (19)
- The endogenous opioid system in Gilles de la Tourette syndrome. (1986) (19)
- Mood-dependent fluctuations in the severity of tardive dyskinesia and psoriasis vulgaris in a patient with schizoaffective disorder: possible role of melatonin. (1990) (19)
- The relationship of thought disorder to third ventricle width and calcification of the pineal gland in chronic schizophrenia. (1993) (19)
- Treatment of Parkinson's disease with magnetic fields reduces the requirement for antiparkinsonian medications. (1994) (19)
- Multiple sclerosis: relationship between seasonal variations of relapse and age of onset. (1993) (19)
- Pineal calcification in schizophrenia Relationship to age of onset and tardive dyskinesia (1991) (18)
- Evidence for underactivity of the opioid system in neuroleptic-induced akathisia (1984) (18)
- Baclofen in hemifacial spasm. (1984) (18)
- Spontaneous pain, hyperpathia and wasting of the hand due to parietal lobe haemorrhage. (1985) (18)
- Naltrexone suppresses abnormal sexual behavior in Tourette's syndrome. (1988) (18)
- Back pain as an early symptom of Parkinson's disease. (1982) (18)
- Tryptophan availability and the susceptibility to stress in multiple sclerosis: a hypothesis. (1996) (18)
- A case of Tourette's syndrome with midbrain involvement. (1988) (18)
- Phenytoin toxicity induced by interaction with ibuprofen. (1982) (18)
- Relationship of nocturnal melatonin levels to duration and course of multiple sclerosis. (1994) (18)
- Dysautonomia in Parkinson's disease: relationship to motor disability. (1992) (17)
- Progressive cognitive improvement in multiple sclerosis from treatment with electromagnetic fields. (1997) (17)
- Parkinsonism induced by captopril. (1985) (17)
- Paralysis of upward gaze as a presenting symptom of vitamin B12 deficiency. (1984) (17)
- Parkinsonism secondary to neurosyphilis. A case report. (1983) (17)
- Gonadotropin deficiency in Tourette's syndrome: a preliminary communication. (1988) (17)
- Weak magnetic fields antagonize the effects of melatonin on blood glucose levels in Parkinson's disease. (1993) (17)
- Pineal calcification and its relationship to the fatigue of multiple sclerosis. (1994) (17)
- Chronic relapsing multiple sclerosis: a case of rapid recovery by application of weak electromagnetic fields. (1995) (17)
- Acute exacerbation of Parkinson's disease with sulindac (1985) (17)
- Hemifacial spasm in tuberculous meningitis. (1983) (17)
- The effects of picoTesla range magnetic fields on perceptual organization and visual memory in parkinsonism. (1993) (16)
- Successful treatment of neuroleptic-induced akathisia with baclofen and clonazepam. A case report. (1985) (16)
- Naloxone withdrawal exacerbates Tourette syndrome. (1986) (16)
- The pineal gland and the clinical course of multiple sclerosis. (1992) (16)
- Improvement in word-fluency performance in Parkinson's disease by administration of electromagnetic fields. (1994) (16)
- Magnetic fields mimic the behavioral effects of REM sleep deprivation in humans. (1992) (16)
- Aggressive behavior in schizophrenia: relationship to age of onset and cortical atrophy. (1993) (16)
- Self-mutilation in Tourette's Syndrome (1988) (16)
- Risk factors for neuroleptic-induced movement disorders. (1991) (16)
- Drug-induced parkinsonism: relationship to age at onset of schizophrenia. (1991) (16)
- Vitamin C in the treatment of schizophrenia. (1993) (15)
- Magnetic fields alter the circadian periodicity of seizures. (1992) (15)
- Improvement in word-fluency performance in patients with multiple sclerosis by electromagnetic fields. (1994) (15)
- L-tryptophan supplementation in Parkinson's disease. (1989) (15)
- The pineal gland, cataplexy, and multiple sclerosis. (1995) (15)
- Olfactory hallucinations in Parkinson's disease. (1981) (15)
- Treatment with electromagnetic fields improves dual-task performance (talking while walking) in multiple sclerosis. (1997) (15)
- Failure of clonidine to ameliorate the symptoms of restless legs syndrome. (1987) (15)
- Subjective awareness of abnormal involuntary movements in schizophrenia. (1993) (15)
- The accelerated aging hypothesis of Parkinson's disease is not supported by the pattern of circadian melatonin secretion. (1997) (15)
- The relationship between melatonin secretion and serum cholesterol in patients with multiple sclerosis. (1994) (15)
- Blepharospasm associated with palatal myoclonus and communicating hydrocephalus (1984) (14)
- Anticholinergic-induced analgesia: possible role for the cholinergic system in abnormal sensory symptoms in Parkinson's disease. (1986) (14)
- Cholinergic mechanisms in Gilles de la Tourette's syndrome. (1995) (14)
- The relationship of tardive dyskinesia to positive schizophrenia. (1991) (14)
- Infantile autism: a dysfunction of the opioids? (1986) (14)
- Psychotic behavior associated with cerebellar pathology. (1993) (14)
- Colchicine ameliorates constipation in Parkinson's disease. (1984) (14)
- Melatonin mediates the antidyskinetic effects of naloxone in tardive dyskinesia. (1989) (14)
- Weak electromagnetic fields restore dream recall in patients with multiple sclerosis. (1995) (14)
- Isolated ocular myopathy and celiac disease in childhood (1983) (14)
- Treatment with weak electromagnetic fields restores dream recall in a parkinsonian patient. (1997) (14)
- Locus coeruleus-pineal melatonin interactions and the pathogenesis of the "on-off" phenomenon associated with mood changes and sensory symptoms in Parkinson's disease. (1989) (13)
- Suicidal behavior is attenuated in patients with multiple sclerosis by treatment with electromagnetic fields. (1996) (13)
- Phenytoin toxicity and co-trimoxazole. (1985) (13)
- Pineal calcification and subtypes of tardive dyskinesia. (1990) (13)
- The relationship between ECT nonresponsiveness and calcification of the pineal gland in bipolar patients. (1990) (13)
- Spinal dopamine mechanisms and primary sensory symptoms in Parkinson's disease. (1987) (13)
- Resolution of dysarthria in multiple sclerosis by treatment with weak electromagnetic fields. (1995) (13)
- The association of pineal calcification with drug-induced dystonic movements. (1990) (13)
- Estrogen as adjuvant treatment of Tourette syndrome. (1987) (13)
- Motor dysfunction following chronic exposure to a fluoroalkane solvent mixture containing nitromethane. (1984) (13)
- Transient hemiparesis caused by phenytoin toxicity. A case report. (1983) (13)
- Menstrual-related fluctuations in Tourette's syndrome. (1987) (13)
- Endogenous opioid system in catatonia (1985) (12)
- Abnormal EEG and calcification of the pineal gland in schizophrenia. (1992) (12)
- Atrophy of the cerebellar vermis: Relevance to the symptoms of schizophrenia (1991) (12)
- Toxic irreversible encephalopathy induced by lithium carbonate and haloperidol. A report of 2 cases. (1983) (12)
- Treatment with AC pulsed electromagnetic fields improves the response to levodopa in Parkinson's disease. (1997) (12)
- Premenstrual exacerbation of symptoms in multiple sclerosis is attenuated by treatment with weak electromagnetic fields. (1995) (12)
- Paroxysmal itching in multiple sclerosis during treatment with external magnetic fields. (1994) (12)
- Alzheimer's disease and the pivotal role of the hypothalamus and the intrinsic opioid system. (1987) (12)
- Reversal of visuospatial deficit on the Clock Drawing Test in Parkinson's disease by treatment with weak electromagnetic fields. (1995) (12)
- Phenobarbital-induced Tourette-like symptoms. (1986) (12)
- Improvement in short-term visual memory by weak electromagnetic fields in Parkinson's disease. (1995) (12)
- The hypothalamus in Tourette's syndrome. (1987) (12)
- Abnormal opiate receptor functions in Tourette's syndrome. (1989) (12)
- Treatment with Electromagnetic Fields Alters the Clinical Course of Chronic Progressive Multiple Sclerosis-A Case Report (1996) (12)
- Adult‐onset focal dystonia (1985) (12)
- Mechanisms of action of ECT in Parkinson's disease: possible role of pineal melatonin. (1990) (12)
- Serotonergic neuronal sprouting as a potential mechanism of recovery in multiple sclerosis. (1999) (12)
- Application of weak electromagnetic fields facilitates sensory-motor integration in patients with multiple sclerosis. (1996) (11)
- Attenuation of epilepsy with application of external magnetic fields: a case report. (1992) (11)
- Orofacial dyskinesia induced by baclofen in a patient with hypothyroidism. (1986) (11)
- A neuromagnetic view of hippocampal memory functions. (1998) (11)
- Seasonal panic disorder responsive to light therapy (1991) (11)
- Cocaine addiction: relationship to seasonal affective disorder. (1992) (11)
- Seborrhea and persistent tardive dyskinesia. (1990) (11)
- Parkinsonism caused by chronic subdural haematoma. A case report. (1982) (11)
- Reversal of an acute parkinsonian syndrome associated with multiple sclerosis by application of weak electromagnetic fields. (1996) (11)
- Blepharospasm--successful treatment with baclofen and sodium valproate. A case report. (1983) (11)
- The pineal gland and the menstrual cycle. (1992) (11)
- I. Role of the pineal gland in multiple sclerosis: a hypothesis. (1997) (11)
- Serotonergic mechanisms in levodopa-induced "on-off" and sleep disorders in Parkinson's disease. (1988) (11)
- Nitrous oxide ameliorates spasmodic torticollis. (1985) (11)
- Pineal calcification and its relationship to hallucinations in schizophrenia. (1992) (11)
- The effects of baclofen in the restless legs syndrome: evidence for endogenous opioid involvement. (1988) (10)
- Nicotinic acid deficiency induced by sodium valproate. (1984) (10)
- Impairment of depth perception in multiple sclerosis is improved by treatment with AC pulsed electromagnetic fields. (1999) (10)
- The opioid system in the restless legs and nocturnal myoclonus syndromes. (1986) (10)
- Tourette syndrome: successful treatment with clonidine and oxycodone (1986) (10)
- The relationship of pineal calcification to cerebral atrophy on CT scan in multiple sclerosis. (1994) (10)
- Pineal melatonin functions and the depression of Parkinson's disease: a hypothesis. (1990) (10)
- Recurrence of complex motor and vocal tics in an elderly woman responsive to opiates. (1989) (10)
- Tardive dyskinesia induced by sulpiride in a patient with hypothyroidism. (1986) (10)
- Total external ophthalmoplegia induced by phenytoin. A case report. (1984) (10)
- Reversible quadriplegia in a patient with giant-cell arteritis. (1982) (10)
- Brief communication: electromagnetic fields improve visuospatial performance and reverse agraphia in a parkinsonian patient. (1996) (10)
- Transcranial AC pulsed applications of weak electromagnetic fields reduces freezing and falling in progressive supranuclear palsy: a case report. (1998) (10)
- Clomiphene citrate in Tourette's syndrome. (1988) (10)
- Neuroleptic-opioid interaction: relevance to tardive dyskinesia. (1986) (10)
- Acute psychosis in a woman with a prolactinoma. (1987) (10)
- Clonazepam-induced Tourette syndrome in a subject with hyperexplexia. (1987) (9)
- Inhibitory effects of carbamazepine on clonidine-induced aggressive behavior in mice. (1988) (9)
- Efficacy of trazodone in narcolepsy. (1985) (9)
- Tardive dyskinesia in bipolar disorders: possible role of pineal melatonin. (1990) (9)
- AC pulsed electromagnetic fields-induced sexual arousal and penile erections in Parkinson's disease. (1999) (9)
- Alpha melanocyte stimulating hormone (MSH) in Tourette's syndrome. (1989) (9)
- Effects of picotesla flux electromagnetic fields on dopaminergic transmission in Tourette's syndrome. (1996) (9)
- Writer's cramp and the endogenous opioid system. (1986) (9)
- L-tryptophan in neuroleptic-induced tardive dyskinesia. (1988) (9)
- Treatment with weak electromagnetic fields attenuates carbohydrate craving in a patients with multiple sclerosis. (1996) (9)
- Naltrexone attenuates the antiparkinsonian effects of picoTesla range magnetic fields. (1994) (9)
- Neuroradiological covariates of drug-induced parkinsonism and tardive dyskinesia in schizophrenia. (1991) (9)
- Improvement of body image perception in Parkinson's disease by treatment with weak electromagnetic fields. (1995) (9)
- Naloxone and tardive dyskinesia (1985) (9)
- Enkephalinergic mechanisms in the "compensated" phase of Parkinson's disease. (1988) (9)
- Magnetic fields and the habenular complex. (1991) (9)
- Mechanisms of recovery in mptp-induced parkinsonism (1988) (8)
- Meningococcal meningitis presenting with bilateral deafness and ataxia. (1984) (8)
- Speech impairment in Parkinson's disease is improved by transcranial application of electromagnetic fields. (1997) (8)
- Yawning and stretching--a behavioral syndrome associated with transcranial application of electromagnetic fields in multiple sclerosis. (1998) (8)
- The role of melatonin in the antipsychotic and motor-side effects of neuroleptics: a hypothesis. (1992) (8)
- Sodium valproate-induced analgesia: possible role of the GABA-ergic system in pain mechanism. (1986) (8)
- Treatment with AC pulsed electromagnetic fields normalizes the latency of the visual evoked response in a multiple sclerosis patient with optic atrophy. (1998) (8)
- Clomiphene citrate in Tourette's syndrome. (1987) (8)
- Lithium‐induced visual hallucinations: Evidence for possible opiod mediation (1985) (8)
- Successful treatment of cerebellar tremor with clonazepam. (1985) (8)
- Treatment of writer's cramp with sodium valproate and baclofen. A case report. (1983) (8)
- Alpha rhythm and the pineal gland. (1992) (8)
- The relationship of pineal calcification to subtypes of tardive dyskinesia in bipolar patients. (1990) (8)
- Abnormal growth hormone response to naloxone challenge in Tourette's syndrome. (1987) (8)
- “Lhermitte's sign” as a presenting symptom of subacute combined degeneration of the cord (1983) (8)
- Reversal of a visuoconstructional disorder by weak electromagnetic fields in a child with Tourette's syndrome. (1997) (8)
- Calcification of the choroid plexus as a marker of depression in schizophrenia (1990) (8)
- The head retraction reflex — its specificity in Parkinson's disease (1982) (8)
- Melatonin supplements for aging. (1996) (8)
- Hypothalmic-Mediated Immune Mechanisms and Their Relevance to the Pathoettology of Parkinson's Disease (1987) (8)
- Clonidine in neuropsychiatric disorders: a review. (1987) (8)
- Resolution of partial cataplexy in multiple sclerosis by treatment with weak electromagnetic fields. (1996) (8)
- Nomifensine for emotional incontinence in the elderly. (1985) (8)
- The hypothalamus in MPTP-induced parkinsonism (1990) (8)
- Beneficial effect of sodium valproate and baclofen in spasmodic torticollis. A case report. (1984) (7)
- Beneficial effects of imipramine on Tourette's syndrome. (1988) (7)
- Weak electromagnetic fields improve body image perception in patients with multiple sclerosis. (1995) (7)
- Congenital fibre type disproportion. A case report. (1981) (7)
- Elevated cerebrospinal fluid lactic acid levels in Creutzfeldt-Jakob disease. (1988) (7)
- Carbon monoxide poisoning. (1984) (7)
- Coexisting bipolar affective disorder and multiple sclerosis: the role of the pineal gland. (1991) (7)
- Opioid-serotoninergic dysregulation in the pathophysiology of Tourette's syndrome. (1988) (7)
- Hypothalamic-locus coeruleus mechanisms in the pathophysiology of "on-off" in L-dopa treated Parkinson's disease: a hypothesis. (1989) (7)
- Effect of weak electromagnetic fields on body image perception in patients with multiple sclerosis. (1996) (7)
- Transient Gilles de la Tourette syndrome following alcohol withdrawal. (1985) (7)
- Melanocyte-stimulating hormone in tardive dyskinesia (1989) (7)
- Naloxone causes urinary urgency. (1986) (7)
- Magnesium deficiency in chronic schizophrenia. (1991) (7)
- Postpartum psychosis and the pineal gland. (1992) (7)
- The relationship between ECT responsiveness and subtypes of tardive dyskinesia in bipolar patients. (1990) (7)
- Reversal of alexia in multiple sclerosis by weak electromagnetic fields. (1995) (7)
- Opioid modulation of gonadotrophin release in Tourette's syndrome. (1988) (7)
- Electromagnetic fields for treatment of multiple sclerosis. (1996) (7)
- Amine accumulation: a possible precursor of Lewy body formation in Parkinson's disease. (1992) (7)
- Posttraumatic cerebellar syndrome: response to l-tryptophan. (1989) (7)
- Hypothalamic compensatory mechanisms in Parkinson's disease. (1989) (7)
- Melanocyte stimulating hormone (MSH) in the restless-legs syndrome. (1989) (7)
- Hemichorea-hemiballismus caused by lacunar infarction in the basal ganglia. A case report. (1983) (7)
- Edentulousness and neuroleptic-induced neck and trunk dyskinesia. (1990) (7)
- Reversal of the bicycle drawing direction in Parkinson's disease by AC pulsed electromagnetic fields. (1998) (7)
- Reversal of cognitive impairment in an elderly parkinsonian patient by transcranial application of picotesla electromagnetic fields. (1997) (7)
- Adrenal medullary tissue transplantation in Parkinson's disease. (1988) (6)
- Zinc deficiency and cerebellar disease. (1991) (6)
- Sodium valproate and baclofen for Sydenham's chorea. (1983) (6)
- The opioid system in Gilles de la Tourette's syndrome (1985) (6)
- Opioids, dopamine, and restless legs syndrome. (1985) (6)
- Melatonin secretion and the pathophysiology of Meige's disease (idiopathic orofacial dystonia): a hypothesis. (1990) (6)
- Neuroleptic malignant syndrome and the endogenous opiate system (1985) (6)
- Choreo-athetosis induced by phenytoin in an epileptic child. A case report. (1981) (6)
- Neuroleptic-mediated hypothalamic deregulation of central insulin and peripheral glucose metabolism in tardive dyskinesia: a hypothesis. (1988) (6)
- Re., Sensory symptoms in Parkinson's disease. (1986) (6)
- Sensory symptoms in Parkinson's disease and the opioid system. (1985) (6)
- Relationship of neuroleptic-induced akathisia to drug-induced parkinsonism (1990) (6)
- Cerebellar dysfunction in hypothyroidism. (1982) (6)
- Seasonal panic disorder: a possible variant of seasonal affective disorder. (1992) (6)
- "Down regulation" of 5-HT2 receptors: possible role of melatonin and significance for negative schizophrenia. (1991) (6)
- Pineal calcification in relation to menopause in schizophrenia. (1992) (6)
- Tuberculous meningitis presenting with trismus. (1982) (6)
- Transient global amnesia induced by lorazepam. (1985) (6)
- The blink reflex in hydrocephalic infants and children. (1982) (6)
- Nomifensine for “Emotional Incontinence” of the Pseudobulbar Type (1985) (6)
- Dopaminergic supersensitivity factors in Tourette's syndrome: a hypothesis. (1989) (6)
- Brief Communication CALCIFICATION OF THE PINEAL GLAND: RELATIONSHIP TO LATERALITY OF THE EPILEPTIC FOCI IN PATIENTS WITH COMPLEX PARTIAL SEIZURES (1992) (6)
- Deregulation of hypothalamic opioid and luteinizing hormone releasing factor (LHRF) activity and its relevance to Tourette's syndrome. (1988) (6)
- Autonomic functions in the early stages of Parkinson's disease. (1994) (6)
- Neuroleptic malignant syndrome and the opioid system. (1985) (6)
- Propranolol‐induced tardive dyskinesia in a patient with akathisia (1985) (6)
- Increased incidence of neuroleptic-induced perioral movements in the rat by hyperglycemia. (1990) (6)
- Footballer's migraine--a report of 2 cases. (1983) (6)
- Amphetamine-induced rotational behavior in rats: relationship to hypothalamic and striatal degeneration. (1993) (6)
- Orofacial dyskinesias associated with lorazepam therapy. (1986) (6)
- Baclofen responsive posttraumatic epilepsy. (1987) (6)
- Tardive dyskinesia associated with depression in a bipolar patient: possible role of melatonin. (1990) (6)
- Gilles de la Tourette's syndrome associated with chronic schizophrenia. (1988) (6)
- Neuroradiological facets of cognitive abnormality in schizophrenia. (1991) (6)
- Pro-opiomelanocortin (POMC) processing in Parkinson's disease. (1989) (5)
- Facial myokymia--a false localizing sign in obstructive communicating hydrocephalus. A case report. (1985) (5)
- Effect of weak electromagnetic fields on the amplitude of the pattern reversal VEP response in Parkinson's disease. (1996) (5)
- Choroid plexus calcification: a biological marker of suicidality. (1991) (5)
- Heightened cortisol response to administration of naloxone in Tourette's syndrome. (1988) (5)
- Phenytoin toxicity induced by antituberculosis drugs. (1982) (5)
- Urinary incontinence associated with clonazepam therapy. (1983) (5)
- Intracranial haemorrhage in a 26 year-old woman with idiopathic thrombocytopenic purpura. (1987) (5)
- Successful treatment of respiratory dyskinesia with picoTesla range magnetic fields. (1994) (5)
- Melatonin potentiates the effects of naloxone on reserpine-induced catalepsy in the rat. (1989) (5)
- Yawning and stretching induced by transcranial application of AC pulsed electromagnetic fields in Parkinson's disease. (1999) (5)
- Alpha-melanocyte-stimulating hormone: possible role in the pathophysiology of acute drug-induced dystonia. (1990) (5)
- Sleep disorders in Tourette's syndrome. (1987) (5)
- Lack of a correlation between demyelinating plaques on MRI scan and clinical recovery in multiple sclerosis by treatment with electromagnetic fields. (1997) (5)
- Transient hemiparesis--a rare complication of phenytoin toxicity. (1983) (5)
- Naloxone in progressive supranuclear palsy. (1985) (5)
- A tribute to Professor Sidney Weinstein on his 70th birthday. (1992) (5)
- The relationship of peripheral trauma and pain to dystonia G.D. Schott, J. Neurol. Neurosurg. Psychiat., 48 (1985) 698–701 (1986) (5)
- Treatment with P-chloroamphetamine enhances the development of neuroleptic-induced orofacial dyskinesias in the rat. (1989) (5)
- Phenothiazine-induced sleep apneas and the opioid system. (1986) (5)
- Transient global amnesia: a presentation of subarachnoid haemorrhage (2004) (5)
- Wernicke-Korsakoff encephalopathy and the endorphin system. (1986) (5)
- Treatment with electromagnetic field alters the clinical course of chronic progressive multiple sclerosis--a case report. (1996) (5)
- Neuroleptic Malignant Syndrome (1986) (5)
- Reversal of visuospatial hemi-inattention in patients with chronic progressive multiple sclerosis by treatment with weak electromagnetic fields. (1994) (5)
- Deregulation of hypothalamic dopamine and opioid activity and the pathophysiology of self-mutilatory behavior in Tourette's syndrome. (1987) (5)
- The relationship of pineal calcification to tardive dyskinesia. (1990) (5)
- Sensitivity of dopamine receptors in the lateral hypothalamus is altered in 6-hydroxydopamine treated rats. (1992) (5)
- Bilateral ballism induced by ibuprofen in a schizophrenic patient. (1987) (5)
- Opioid hypofunction in Parkinson's disease. (1985) (5)
- The electromyographic silent period in Huntington's chorea--a comparison between childhood and adult values. (1982) (5)
- Parkinsonism induced by a monoamine oxidase inhibitor. (1986) (5)
- The Eaton-Lambert syndrome. (1983) (5)
- Pineal melatonin and sensory symptoms in Parkinson disease (1989) (5)
- Isolated failure of upward gaze as a sign of chronic subdural haematoma. (1982) (5)
- Pineal calcification and anticonvulsant responsiveness to artificial magnetic stimulation in epileptic patients. (1991) (5)
- Sulcal size and neuroleptic-induced akathisia (1990) (5)
- Biological determinants and risk factors for tardive dyskinesia in schizophrenia. (1993) (5)
- Is excessive opioid activity relevant to the Korsakoff psychosis? (1986) (4)
- Parkinsonism induced by diazepam (1986) (4)
- Unusual presentation of primary klebsiella meningitis: successful treatment with cefotaxime. (1983) (4)
- Speech blockage induced by maprotiline. (1986) (4)
- Baclofen in the treatment of post-amputation autonomous stump movements. (1987) (4)
- Dystonia as the presenting manifestation of multiple sclerosis. (1992) (4)
- Weak electromagnetic fields reverse visuospatial hemi-inattention in Parkinson's disease. (1995) (4)
- ECT, opioid system, and motor response in Parkinson's disease (1986) (4)
- Progressive multifocal leuco-encephalopathy. (1983) (4)
- New vistas in chronic schizophrenia. (1988) (4)
- Analgesic nitrous oxide in alcohol withdrawal: the role of melatonin. (1991) (4)
- Early versus late-onset Parkinson's disease: the role of the locus coeruleus. (1990) (4)
- Persistent akathisia associated with early dyskinesia. (1984) (4)
- Parkinsonism induced by methyldopa. (1984) (4)
- Amelioration of experimental parkinsonism by intrahypothalamic administration of haloperidol. (1992) (4)
- Cerebral glucose utilization in Parkinson's disease. (1985) (4)
- Depression as a cause of hallucinations in Parkinson's disease. (1985) (4)
- Neurochemical perspectives of the narcoleptic syndrome. (1988) (4)
- Impairment of somatosensory feedback control of the tongue in Parkinson's disease: effect of L-Dopa therapy. (1982) (4)
- Acute deterioration and death in infancy due to posterior fossa tumour. A case report. (1981) (4)
- Hemichorea--a late sequel of an extradural haematoma. (1983) (4)
- Melatonin as a mediator of atypical antipsychotic drug effects (1991) (4)
- Cerebral cysticercosis presenting as senile dementia. (1983) (4)
- Reversible parkinsonism in normal pressure hydrocephalus. (1982) (4)
- The electromyographic silent period is reduced in individuals at risk for Huntington's disease. (1988) (4)
- MIF-induced augmentation of melatonin functions: possible relevance to mechanisms of action of MIF-1 in movement disorders. (1990) (4)
- Cerebral cysticercosis presenting as progressive dementia. (1987) (4)
- Melatonin, and opioid peptide interactions in tardive dyskinesia. (1989) (4)
- Alzheimer's disease and hypothalamic-mediated endorphinergic mechanisms (1986) (4)
- Tardive dyskinesia and the pineal gland. (1988) (3)
- URINARY INCONTINENCE IN PATIENT ON LONG-TERM BROMOCRIPTINE (1983) (3)
- Essential tremor--successful treatment with aminophylline. A case report. (1983) (3)
- Sleep disorders and Gilles de la Tourette's syndrome (1985) (3)
- The opioid-noradrenergic link in Gilles de la Tourette's syndrome. (1985) (3)
- Delusional depression in Parkinson's disease. (1993) (3)
- Parkinsonian micrographia reversed by treatment with weak electromagnetic fields. (1995) (3)
- The role of cortical and subcortical mechanisms in voluntary movement in Parkinson's disease. An electrophysiological study. (1982) (3)
- Subacute toxic delirium caused by nitrous oxide may be an acute withdrawal state. (1984) (3)
- The biological significance of yawning elicited by application of electromagnetic fields in multiple sclerosis. (1997) (3)
- Aggressive dementia in normal pressure hydrocephalus. (1984) (3)
- The forum for scientific controversies. (1990) (3)
- Prolactin secretion in multiple sclerosis. (1991) (3)
- Parkinsonism after hysterectomy. (1982) (3)
- Opiate antagonists in experimental stroke. (1986) (3)
- Internuclear Ophthalmoplegia in Tuberculous Meningitis (1984) (3)
- Interictal temporal lobe epileptiform discharges and their relationship to secondarily generalized epilepsy. (1988) (3)
- Fluctuations of symptoms during manic-depressive mood changes in Tourette's syndrome. (1988) (3)
- Hemolysis during cardiopulmonary bypass (1982) (3)
- Melanocyte-stimulating hormone and persistent tardive dyskinesia: a hypothesis. (1990) (3)
- Opioid neuronal denervation in Gilles de la Tourette syndrome. (1987) (3)
- Naloxone does not benefit levodopa‐induced hallucinations in Parkinson's disease (1984) (3)
- Opioid induced unconsciousness reversed by changes in opioid cholinergic and adrenergic function. (1985) (3)
- Sexual hormones in the pathophysiology of Tourette's syndrome. (1988) (3)
- The effects of external picotesla range magnetic fields on the EEG in Parkinson's disease: a follow up study. (1994) (3)
- Autoimmune mechanisms in Parkinson's disease. (1989) (3)
- Parkinsonism, gait apraxia and dementia associated with intracranial calcifications. A case report. (1983) (3)
- Calcification of the pineal gland: relationship to laterality of the epileptic foci in patients with complex partial seizures. (1992) (3)
- Antimanic effects of clonidine and the endogenous opioid system. (1985) (3)
- Melatonin and petit-mal epilepsy: an hypothesis. (1992) (3)
- Nomifensine exacerbates orofacial dyskinesia in hypothyroidism. (1985) (2)
- Treatment with AC pulsed electromagnetic fields induces vivid colored dreams in multiple sclerosis (1998) (2)
- Nadolol in posttraumatic intention tremor. (1986) (2)
- Non-dopaminergic mechanisms in adrenal medullary transplantation for Parkinson's disease. (1989) (2)
- L-tryptophan in drug-induced movement disorders with insomnia. (1986) (2)
- Weak electromagnetic fields increase the amplitude of the pattern reversal VEP response in patients with multiple sclerosis. (1996) (2)
- Auto-tolerance to the endogenous opioids and sleep. (1985) (2)
- Failure of amantadine hydrochloride to alter immune responses in the experimental allergic encephalomyelitis model of neuroautoimmune disease. (1988) (2)
- Hypothalamic dysregulation of immune responses in focal dystonia (1987) (2)
- Bidirectional effect of electromagnetic fields on ketanserin-induced yawning in patients with multiple sclerosis: the role of melatonin. (1996) (2)
- Third ventricular width and its relationship to mode of onset of schizophrenia. (1993) (2)
- Nimifensine exacerbates depression and seizures in an epileptic patient (1984) (2)
- Re: Cholinergic mechanisms of pain relief by antidepressants. (1986) (2)
- Wernicke-Korsakoff's syndrome and the opioid system. (1987) (2)
- Voluntary responses to peripheral stimulation in Parkinson's disease. An electrophysiological study. (1981) (2)
- Bickerstaff's brainstem encephalitis in Johannesburg. A case report. (1983) (2)
- Adult neuronal ceroid lipofuscinosis (Kufs' disease). A sporadic case. (1981) (2)
- Topographic subtypes of tardive dyskinesia: relationship to seborrhea. (1990) (2)
- Bilateral internuclear ophthalmoplegia reversed by naloxone. (1984) (2)
- Somatosensory feedback mechanisms in tongue and speech muscle movements. (1981) (2)
- The opioid system and the reversibility of the dementia in normal pressure hydrocephalus. (1987) (2)
- Phenelzine in migraine headaches. (1987) (2)
- Nomifensine in advanced parkinsonism. (1985) (2)
- Further speculations on possible dopamineopioid link in autism (1986) (2)
- Noradrenaline and Tardive Dyskinesia (1984) (2)
- Suicidal behavior and tardive dyskinesia. (1991) (2)
- Brain reward systems and Tourette's syndrome. (1989) (2)
- Hypothalamic-mediated immune mechanisms and their relevance to the pathoetiology of Parkinson's disease. (1987) (2)
- Hemifacial spasm--successful treatment with baclofen. (1984) (2)
- Neuroleptic-induced akathisia: a role for MSH peptides (2004) (2)
- Nomifensine-induced orofacial dyskinesia and Sydenham's chorea. (1987) (2)
- Tourette syndrome. (1987) (2)
- Weak electromagnetic fields potentiate the effects of 4-aminopyridine in multiple sclerosis. (1996) (2)
- Dopamine and insulin interact to modulate in vitro glucose transport in rat adipocytes. (1988) (2)
- Hematuria following tricylic therapy. (1984) (2)
- Melanocyte-stimulating hormone (MSH) and tardive dyskinesia (1989) (2)
- Serial epilepsy caused by levodopa/carbidopa administration in two patients on hemodialysis. (1990) (2)
- Tourette syndrome: a case for noradrenergic and opiatergic mechanisms. (1986) (2)
- Late-onset schizophrenia: relationship to awareness of abnormal involuntary movements and tobacco addiction. (1993) (2)
- Stephen Walter Ranson (1880-1942): a pioneer in hypothalamic research. (1994) (2)
- "Positive" and "negative" movement disorders in schizophrenia. (1992) (2)
- Negative schizophrenia as a variant of parkinsonism (1991) (2)
- How does verapamil exert an antimanic effect? (1986) (2)
- Nifedipine‐induced Psychosis (1985) (1)
- The Shy-Drager syndrome. (1983) (1)
- Meningioma presenting with recurrent retrobulbar neuritis. (1982) (1)
- Head retraction reflex and parkinsonism--a preliminary study. (1982) (1)
- Brain development and the phylogenesis of writing and drawing direction. (1982) (1)
- Subcortical arteriosclerotic encephalopathy (Binswanger's disease). (1983) (1)
- The pineal gland and the mechanisms of tardive dyskinesia. (1990) (1)
- Tryptophan in the amelioration of drug-induced tardive dyskinesia (1990) (1)
- Haloperidol-sensitive sigma receptor and the role of the pineal gland in dystonia (1991) (1)
- The effect of external stimulation on arousal and motor performance in Parkinson's disease. An experimental study. (1982) (1)
- Piracetam Causes Confusion in a Patient with Temporal Lobe Epilepsy (1985) (1)
- Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). A case report. (1982) (1)
- Letter to the Editor: Dysmenorrhea and the Pineal Gland (1992) (1)
- Dosage of antituberculosis agents in tuberculosis meningitis. (1983) (1)
- Hydrocephalus and reversible spastic gait in an adult. (1982) (1)
- Adrenocorticotrophic hormone (ACTH) and movement disorders. (1987) (1)
- Anergia and depression as early features of multiple sclerosis. (1982) (1)
- Low dose bromocriptine ameliorates hallucinations in a demented parkinsonian patient. (1987) (1)
- Paralysis of ocular divergence--a sign of raised intracranial pressure. (1982) (1)
- Positive symptoms and chronicity of illness in schizophrenia. (1993) (1)
- The relationship of serotonin metabolism and melatonin secretion to the pathophysiology of tardive dyskinesia. (1989) (1)
- Latency and successive reaction time in Parkinson's disease--the effects of carbidopa and amantadine. (1981) (1)
- ECT, opioids, and motility in Parkinson's disease (1986) (1)
- CSF Met‐enkephalin levels in Parkinson's disease (1985) (1)
- CSF and plasma levels of pro-opiomelanocortic-related peptides. (1986) (1)
- Letter to the Editor AUTOIMMUNE MECHANISMS IN PARKINSON'S DISEASE (1989) (1)
- Jaw reflexes in local tetanus. (1981) (1)
- Nomifensine exacerbates orfacial dyskinesia in hypohyrodism (1985) (1)
- Maprotiline for disordered cognitive function in Parkinson's disease. (1986) (1)
- Amantadine for levodopa resistant parkinsonism. (1987) (1)
- Naloxone ameliorates presyncopal sensations in progressive supranuclear palsy. (1987) (1)
- Tardive dyskinesia: a role for the endogenous opioid system. (1986) (1)
- The hypothalamic luteinizing hormone releasing hormone "pulse generator" and the opioid system in Tourette's syndrome. (1988) (1)
- Paroxysmal episodes of rapid blinking during hallucinatory activity in a schizophrenic patient: a possible mechanism involving pineal-mediated 'fine tuning' of dopaminergic functions. (1990) (1)
- ACTH and the effects of anticholinergic drugs in dystonia. (1989) (1)
- Intraspinal opiates for treatment of intractable pain in the terminally ill cancer patient. (1988) (1)
- Dexamethasone suppression test nonsuppression and tardive dyskinesia (1989) (1)
- The relationship of limbic epilepsy to pineal melatonin functions. (1991) (1)
- Trigeminal neuralgia secondary to hydrocephalus. (1982) (1)
- The long-term impact of treatment with electromagnetic fields on visual memory in Parkinson's disease. (1996) (1)
- Inappropriate sexual behavior and denervation supersensitivity of limbic and midbrain LHRH receptors in Tourette's syndrome. (1988) (1)
- Conjugate deviation of gaze in hepatic encephalopathy. (1982) (1)
- Parkinson's disease and thalassalmia in a South African family of Greek origin. (1983) (1)
- ACTH and its relationship to the cataplectic syndrome. (1989) (1)
- Abnormalities in the brain and schizophrenia. (1990) (1)
- Internuclear ophthalmoplegia in tuberculous meningitis. A report of two cases. (1984) (1)
- Pupillary signs in tuberculous meningitis. (1982) (1)
- Efficacy of Valproate in Manic-Depressive Psychosis: Mechanism of Action and Implications for Pathophysiology (1985) (0)
- Subject Index Vol. 31, 1991 (1991) (0)
- Gonadotrophin responses to naloxone challenge in anorexia nervosa: Evidence for reduced hypothalamic endogenous opioid functions (1987) (0)
- The effect of alcoholism on Parkinson's disease. (1983) (0)
- Does melatonin mediate the therapeutic effects of 5-HT reuptake inhibitors in obsessive compulsive disorder? (1992) (0)
- Clinical Note THE PINEAL GLAND AND THE CLINICAL COURSE OF MULTIPLE SCLEROSIS (1992) (0)
- The Tolosa-Hunt syndrome. (1983) (0)
- Stanley R. Kay (1946–1990) (1991) (0)
- Clinical Case Reports L-TRYPTOPHAN SUPPLEMENTATION IN PARKINSON'S DISEASE (1989) (0)
- Parkinson's Disease (2019) (0)
- Inhibition of growth hormone release by naloxone in adult Tourette's syndrome subjects. (1988) (0)
- Sensory adaptations in cortical lesions. (1982) (0)
- Letter to the editor (1986) (0)
- Deranged modulatory midbrain opioid and gonadotrophin functions: relevance to Tourette's syndrome. (1991) (0)
- Dynorphin deficiency in Tourette's syndrome. (1989) (0)
- Subcortical arteriosclerotic encephalo-pathy (Binswanger's disease) (1983) (0)
- The "therapeutic lag" of anti-depressants and the opioid system. (1987) (0)
- Oculomotor signs in amitriptyline induced coma. (1983) (0)
- Contents Vol. 31, 1999 (1999) (0)
- in hydrocephalic children The blink reflex infants and (1982) (0)
- Inhibition of prolactin release by luteinizing hormone-releasing hormone in Tourette's syndrome. (1988) (0)
- Adult neuronal disease) ceroid lipofuscinosis A sporadic case (1981) (0)
- Effects of the opiate antagonist naloxone on learning and memory in patients with multi-infarct dementia. (1987) (0)
- Facilitation of neuroleptic-induced perioral movements in rats by hyperglycemia (1989) (0)
- The neurotoxicity of MPTP and its relationship to the pathophysiology of Parkinson's disease. (1989) (0)
- Cerebral neoplasm simulating transient ischaemic attacks. A case report. (1983) (0)
- Treatment with AC pulsed electromagnetic fields prevents seasonal exacerbation of symptoms in multiple sclerosis (1998) (0)
- [Corpus callosum agenesia combined with a cyst in the pellucid septum (author's transl)]. (1980) (0)
- The effect of propranolol on parkinsonian tremor induced by peripheral trauma. (1982) (0)
- Potentiation of opiate analgesia with ibuprofen. (1985) (0)
- Clonazepam‐haloperidol therapy in schizophrenia (1988) (0)
- Response (1990) (0)
- Role of androgens in tardive dyskinesia. (1991) (0)
- Metoclopramide-induced dysarthria. (1983) (0)
- Letter to the editor (1986) (0)
- Tremor following peripheral nerve injury. (1986) (0)
- The significance of the basal ganglia for schizophrenia (1991) (0)
- Association of pineal gland calcification with neuroleptic dose in chronic schizophrenia (1991) (0)
- [Familial periodic hypokalaemic paralysis (author's transl)]. (1980) (0)
- Dysmenorrhea and the pineal gland. (1992) (0)
- Clinical Note TREATMENT WITH ELECTROMAGNETIC CLINICAL COURSE OF A PATIENT WITH CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS FIELDS REVERSES THE LONG-TERM (1997) (0)
- Late detection of cerebral glioma causing seizures in childhood. A case report. (1981) (0)
- Transient hemiparesis-a rarecomplication ofphenytoin toxicity (1983) (0)
- The protective function of beta-endorphin in movement disorders. (1989) (0)
- Levodopa withdrawal and the neuroleptic malignant syndrome. (1986) (0)
- CLINICALREPORTS Meningococcal meningitis presenting withbilateral deafness andataxia (1984) (0)
- Brief Communication THE RELATIONSHIP BETWEEN MELATONIN SECRETION AND SERUM CHOLESTEROL IN PATIENTS WITH MULTIPLE SCLEROSIS (1994) (0)
- Letter to the editor (1983) (0)
- Clinical Note NALOXONE AMELIORATES PRESY NCOPAL SENSATIONS IN PROGRESSIVE SUPRANUCLEAR PALSY (1987) (0)
- Paraventricular nucleus-pineal interaction: relevance to tardive dyskinesia. (1992) (0)
- Contents, Vol. 23, 1984 (1984) (0)
- Treatment with weak electromagnetic fields controls drooling in Parkinson's disease. (1996) (0)
- Potential Role of Cannabinoids for Therapy of Neurological Disorders (2019) (0)
- Suicide as a risk factor for tardive dyskinesia (1991) (0)
- Paralysis of conjugate upward gaze in acute decompensating hydrocephalus. (1982) (0)
- Petit mal and learning disorders. (1981) (0)
- The opioid system, seizures and the developing brain. (1987) (0)
- Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) (1982) (0)
- INCREASED INCIDENCE AND SEVERITY OF IN PINEALECTOMIZED RATS NEUROLEPTIC-INDUCED MOVEMENT DISORDER (1989) (0)
- Metoclopramide-induced parkinsonism. (1983) (0)
- Chronic autonomic failure and the endogenous opioid system. (1987) (0)
- Amitriptyline for pain of cortical origin. (1986) (0)
- Failure of haloperidol to alter gonadotropin release in Tourette's syndrome. (1989) (0)
- The hypothalamus in dystonic movement disorders. (1988) (0)
- Depression and benign intracranial hypertension (1986) (0)
- An atypical form of familial myoclonus epilepsy. A case report. (1982) (0)
- Opioid receptor differentiation and Gilles de la Tourette syndrome. (1987) (0)
- Subject Index Vol. 23, 1984 (1984) (0)
- A cortical vs. subcortical distinction of dementia contrasts with the unifying pathoetiology of Alzheimer's and Parkinson's disease. (1987) (0)
This paper list is powered by the following services:
